kinds of machines that deliver radiation, we’ve got all this stuff in the war on cancer, and it’s
I find it very interesting that we have all these walks for the cure of cancer. We’ve got all thewristbands, we’ve got all the donations—”we’re going to find a cure in this decade.” All this
money keeps pouring in
and it all goes to the same guys.
ON-SCREEN TITLE CARD:
PhRMA: New Medicines. New Hope.
The pharmaceutical industry is arguably the most profitable industry on our planet, with it’s
profits being triple that of all of the Fortune 500 companies. [SOURCE: Fortune 4/30/07Company Annual Reports][
] Rising profits result in rising stock prices, the only way this industry can sustain thisprofitable momentum is by continuing to introduce new patented drugs. And since the
pharmaceutical industry relies on the FDA as it’s gatekeeper to introduce these new drugs, it’s
in their best interest to insure the FDA remains as compliant as possible. And since the FDA
is also an office of the United States government, it’s in the government’s best interest to preserve one of it’s most powerful industries.
The former editor-in-chief of the New England Journal of Medicine, Dr. Marcia Angell, hasbeen very outspoken with the idea that...
NARRATOR (reading along with highlighted portions of a Boston Globe article):
... it’s time to take the Food and Drug Administration back from the drug companies. In 1992,
Congress put the fox in the chicken coop. It passed the Prescription Drug User Fee Act, which
authorizes drug companies to pay “user fees” to the FDA for each brand
-name drugconsidered for approval. The user fee act put the FDA on the payroll of the industry itregulates... and it has drastically changed the way it operates. The part of the agency thatreviews new drugs now gets more than half of its money from the pharmaceutical industry.
The FDA’s coziness with industry is underscored by the composition of it’s 18 advisory
outside experts who help evaluate drugs. Incredibly, many of these adviserswork as consultants for drug companies. The FDA behaves as though the pharmaceuticalindustry is its user, not the public.[
NARRATOR (reading along with highlighted portions of the FDA’s Prescription Drug
User Fee Rates for Fiscal Year 2010):
In 2010, the fee revenue paid by the pharmaceutical industry to the FDA has risen to over ahalf a billion dollars
annually. PhRMA now pays over $1.4 million, per application, formost cancer drugs submitted to the FDA
to ensure a timely approval.[
It’s important to understand that neither Congress or the FDA had requested this new fee
structure to occur. Instead, PhRMA itself went to Congress and imposed these new fees ontothe FDA, in essence purchasing
the FDA’s drug evaluation department from both the
government and the public.[
]In a 2007 health policy report,sponsored by Pfizer, supporting the renewal of these user fees, they revealed...